These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Body fluid markers of cartilage changes in osteoarthritis. Thonar EJ; Shinmei M; Lohmander LS Rheum Dis Clin North Am; 1993 Aug; 19(3):635-57. PubMed ID: 8210579 [TBL] [Abstract][Full Text] [Related]
3. Correlation of a novel matrix protein with the degree of cartilage degradation. Schmidt-Rohlfing B; Schneider U; Thomsen M; Bosserhoff AK Rheumatol Int; 2002 Aug; 22(4):165-9. PubMed ID: 12172957 [TBL] [Abstract][Full Text] [Related]
4. Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis. Saxne T; Heinegård D J Rheumatol Suppl; 1995 Feb; 43():71-4. PubMed ID: 7752144 [TBL] [Abstract][Full Text] [Related]
5. Defining the role of molecular markers to monitor disease, intervention, and cartilage breakdown in osteoarthritis. Lohmander LS; Felson DT J Rheumatol; 1997 Apr; 24(4):782-5. PubMed ID: 9101518 [TBL] [Abstract][Full Text] [Related]
6. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
7. Effects of moving training on histology and biomarkers levels of articular cartilage. Qi C; Changlin H J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690 [TBL] [Abstract][Full Text] [Related]
8. [Absolute risk for fracture and WHO guideline. Biological markers for osteoarthritis (OA)]. Date H; Yamada H; Kanaji A; Tajima K; Hayakawa K; Maehara K; Miyazaki K; Masuda H; Clin Calcium; 2007 Jul; 17(7):1071-9. PubMed ID: 17607075 [TBL] [Abstract][Full Text] [Related]
9. A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers. Brandt KD J Rheumatol Suppl; 1989 Aug; 18():39-42. PubMed ID: 2681766 [TBL] [Abstract][Full Text] [Related]
10. Effects of shear stress on articular chondrocyte metabolism. Lane Smith R; Trindade MC; Ikenoue T; Mohtai M; Das P; Carter DR; Goodman SB; Schurman DJ Biorheology; 2000; 37(1-2):95-107. PubMed ID: 10912182 [TBL] [Abstract][Full Text] [Related]
11. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations. Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746 [TBL] [Abstract][Full Text] [Related]
13. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Lohmander LS; Ionescu M; Jugessur H; Poole AR Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777 [TBL] [Abstract][Full Text] [Related]
15. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. Céleste C; Ionescu M; Robin Poole A; Laverty S J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481 [TBL] [Abstract][Full Text] [Related]
16. High levels of aggrecan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthrosis. Ratcliffe A; Grelsamer RP; Kiernan H; Saed-Nejad F; Visco D Acta Orthop Scand Suppl; 1995 Oct; 266():111-5. PubMed ID: 8553838 [No Abstract] [Full Text] [Related]
17. [Biological markers of the destruction of articular cartilage: current aspects]. Vignon E; Conrozier T; Hellio MP; Piperno M; Mathieu P; Richard M Rev Prat; 1997 Nov; 47(17 Suppl):S11-5. PubMed ID: 9453176 [No Abstract] [Full Text] [Related]